Jiangsu Lianhuan Pharmaceutical (600513.SH): Bilastine API Approved for Marketing
Jiangsu Lianhuan Pharmaceutical (600513.SH) announced that the company recently received the "Chemical API Marketing Application Approval Notice" issued by the National Medical Products Administration for the API bilastine. Bilastine is a non-sedating, long-acting antihistamine that selectively antagonizes peripheral H1 receptors, with no affinity for muscarinic receptors and low affinity for other receptors.
Jiangsu Lianhuan Pharmaceutical (600513.SH) announced that the company recently received the "Chemical API Marketing Application Approval Notice" for the API bilastine issued by the National Medical Products Administration. Bilastine is a non-sedating, long-acting antihistamine that selectively antagonizes peripheral H1 receptors, has no affinity for muscarinic receptors, and has low affinity for other receptors.
The company's receipt of the "Chemical API Marketing Application Approval Notice" for bilastine API indicates that the API has passed review and approval, complies with the relevant requirements of domestic drug registration regulations, and is conducive to enriching the company's product line.
Related Articles

Tianjin Tianyao Pharmaceuticals (600488.SH): Marketing application for dexamethasone API approved

Beijing Konruns Pharmaceutical (603590.SH): The KC1101 project has received a clinical trial notice.

Palo Alto Networks (PANW.US) Q1 Earnings Call: Net addition of approximately 170 platformization deployments in the quarter! AI vulnerability discoveries approach 7 times last year's monthly average, enterprises begin tapping emergency budgets
Tianjin Tianyao Pharmaceuticals (600488.SH): Marketing application for dexamethasone API approved

Beijing Konruns Pharmaceutical (603590.SH): The KC1101 project has received a clinical trial notice.

Palo Alto Networks (PANW.US) Q1 Earnings Call: Net addition of approximately 170 platformization deployments in the quarter! AI vulnerability discoveries approach 7 times last year's monthly average, enterprises begin tapping emergency budgets






